Alprenolol demonstrates significant local anaesthetic and anti-arrhythmic properties, primarily by reducing the maximum rate of depolarization in cardiac muscle.
Answers are grounded in this paper and cite their sources.
Alprenolol's antiarrhythmic effects in animals require human validation; leaves open clinical translation beyond preclinical models.
Alprenolol, a beta-adrenoceptor blocking drug reported to have the same potency as propranolol in vitro and in vivo, was found to be four times more active than procaine as a local anaesthetic on frog sciatic nerve.2. At doses of 0.125 mg/kg and above alprenolol protected anaesthetized guinea-pigs against ouabain-induced ventricular fibrillation.3. In isolated rabbit atria, resting potentials were unchanged, and the duration of the action potential was not prolonged, by concentrations of alprenolol up to 10.5 x 10(-6)M. The maximum rate of depolarization (MRD), however, was reduced by 30% at a concentration of 0.525 x 10(-6)M. This was 214 times less than the concentration which reduced the frog action potential height by 25%.4. The concentration of alprenolol required to produce more than 15% decrease in contraction or maximum driven frequency was 3.5 x 10(-6)M.5. As a test of the direct action of alprenolol on isolated cardiac muscle, MRD was also a more sensitive test than the measurement of electrical threshold or conduction velocity.
No takes yet. Share an insight, caveat, or question.
Singh et al. (1970) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: